Hiramatsu, Hidefumi

Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia. [electronic resource] - International journal of hematology Feb 2020 - 303-310 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

1865-3774

10.1007/s12185-019-02771-2 doi


Adolescent
Asian People
B-Lymphocytes
Child
Child, Preschool
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Receptors, Antigen, T-Cell--therapeutic use
Recurrence
Remission Induction
Safety
Treatment Outcome
Young Adult